The international development is crucial to the company. The pharmaceutical market is extremely crowded, thus higher performance in the emerging markets will be increasingly important for the company's global success and sustainable competitive edge.

Along with its international expansion and diversification process, Fidia successfully distributes its products worldwide through an established network of partners operating in the pharmaceutical and biomedical sectors, both on a global and local scale, as well as a direct presence with wholly-owned subsidiaries in USA, Germany, Spain, France, Czech Republic, Slovakia, Romania, Egypt and the Middle East - and of course, Russia.
Fidia extends its global reach in over 100 countries worldwide, and its portfolio comprises medicinal products, medical devices and nutritional supplements.

Strong belief in the value of research and wise choice of partners have contributed to Fidia’s considerable achievements.

- Presence in 100+ countries worldwide
- Wholly-owned subsidiaries in strategic markets
- 50% of total sales generated in foreign markets

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.